Top Markets
#1 QuantixAI QuantixAI +102.94%
#2 MetaDAO MetaDAO +28.44%
#3 龙虾 (Lobster) 龙虾 (Lobster) +27.94%
#4 Rain Rain +23.22%
#5 DOG•GO•TO•THE•MOON (Runes) DOG•GO•TO•THE•MOON (Runes) +19.58%
#6 Bedrock Bedrock +19.11%
#7 Pons Pons +18.33%
#8 Prom Prom +16.34%
#9 Humanity Humanity +14.45%
#10 Stacks Stacks +11.76%
Coin of the day
QuantixAI QuantixAI
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Metsera, Inc. Metsera, Inc.

Metsera, Inc.

MTSR
Rang in Aktien #2738
Metsera, Inc. operates as a clinical-stage biotechnology firm, specializing in... Metsera, Inc. operates as a clinical-stage biotechnology firm, specializing in crafting both injectable and oral nutrient-stimulated hormone analog peptides. These therapeutic compounds are primarily aimed at addressing obesity, overweight conditions, and associated health issues. Its developmental pipeline features MET-097i and MET-233i, both under investigation for treating obesity and overweight patients. Furthermore, Metsera is advancing a potential combination therapy involving MET-233i and MET-097i. The company is also progressing additional drug candidates, including MET-002, MET-224o, MET-067i, and MET-034i, all of which target disorders such as diabetes and obesity. Founded in 2022, Metsera, Inc. maintains its corporate headquarters in New York, New York.
Aktienkurs
$70.50
Zuletzt synchronisiert: 2025-11-14
Marktkapitalisierung
$7.33B
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
116.32%
Land
US
Handel Metsera, Inc. (MTSR)

Kategorie

Healthcare
Kursverlauf für Metsera, Inc. (MTSR)
Höchster Schlusskurs: $72.34 am 2025-11-01

Niedrigster Schlusskurs: $26.50 am 2025-01-01
Kursverlauf der Aktie von Metsera, Inc. von 2025 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -29.98%
2025 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $553.09 42.20%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.02K 50.56%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $158.64 525.80%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $122.47 -12.71%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $772.27 8.67%
CH